ANALGESIC EFFICACY OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS IN EXPERIMENTAL PAIN IN HUMANS

被引:15
作者
WALKER, JS
ARROYO, JF
NGUYEN, T
DAY, RO
机构
[1] ST VINCENTS HOSP, GARVAN INST MED RES, DARLINGHURST, NSW 2010, AUSTRALIA
[2] ST VINCENTS HOSP, DEPT CLIN PHARMACOL & TOXICOL, DARLINGHURST, NSW 2010, AUSTRALIA
[3] ST VINCENTS HOSP, DEPT RHEUMATOL, DARLINGHURST, NSW 2010, AUSTRALIA
关键词
EXPERIMENTAL PAIN; ELECTRICAL STIMULATION; 1ST AND 2ND PAIN; IBUPROFEN DIFLUNISAL; ANALGESIC MODELS;
D O I
10.1111/j.1365-2125.1993.tb00390.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The aim of this study was to establish a simple and reliable experimental pain model that could distinguish the analgesic effects of non-steroidal anti-inflammatory drug (NSAID) treatment from placebo in human volunteers. 2 The reproducibility and reliability over time of subject pain ratings was compared using cutaneous electrical stimuli applied to either the thenar eminence or the ear lobe at varying intensities and modes. Subjects were asked to respond firstly, when the stimulus became clearly sharp and painful ('first pain') and secondly, when the sensation became deep and burning and no further increase in stimulus intensity could be tolerated ('second pain'). 3 Constant voltage stimuli were found to be more reproducible than constant current stimuli. Both phasic (intermittent) and tonic (continuous) stimulation modalities produced 'first' and 'second pain' sensations. The latter sensation was more reproducible, and was perceived as a burning pain which is akin to clinical pain. 4 Analgesics from the NSAID class were found to attenuate reliably only 'second pain' sensations. The analgesic effects of ibuprofen (ibuprofen vs placebo: 0.12 +/- 0.09 vs 0.02 +/- 0.07 volt h-1, P = 0.03; 95% confidence interval for differences (Cl): 0.03-0.18) and diflunisal (diflunisal vs placebo: 0.29 +/- 0.40 vs 0.005 +/- 0.27 volt h-1, P = 0.0001; CI: 0.168-0.407), respectively, could be distinguished from placebo.
引用
收藏
页码:417 / 425
页数:9
相关论文
共 43 条
[1]  
[Anonymous], 1959, MEASUREMENT SUBJECTI
[2]   ACUTE EXPERIMENTAL DENTAL PAIN - A TECHNIQUE FOR EVALUATING PAIN MODULATING PROCEDURES [J].
BINI, G ;
CRUCCU, G ;
MANFREDI, M .
JOURNAL OF NEUROSCIENCE METHODS, 1981, 3 (03) :301-309
[3]   CENTRAL, NALOXONE-REVERSIBLE ANTINOCICEPTION BY DICLOFENAC IN THE RAT [J].
BJORKMAN, R ;
HEDNER, J ;
HEDNER, T ;
HENNING, M .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1990, 342 (02) :171-176
[4]   INFLAMMATORY EDEMA INDUCED BY SYNERGISM BETWEEN CALCITONIN GENE-RELATED PEPTIDE (CGRP) AND MEDIATORS OF INCREASED VASCULAR-PERMEABILITY [J].
BRAIN, SD ;
WILLIAMS, TJ .
BRITISH JOURNAL OF PHARMACOLOGY, 1985, 86 (04) :855-860
[5]  
BROMM B, 1985, METHOD FIND EXP CLIN, V7, P161
[6]   RESPONSE PLASTICITY OF PAIN EVOKED REACTIONS IN MAN [J].
BROMM, B ;
SCHAREIN, E .
PHYSIOLOGY & BEHAVIOR, 1982, 28 (01) :109-116
[7]  
BROMM B, 1984, METHOD FIND EXP CLIN, V6, P405
[8]  
BROMM B, 1988, PAIN, V9, P3
[9]  
BUSCHBAUM MS, 1981, PAIN, V10, P357
[10]  
CHEN ACN, 1980, EXP BRAIN RES, V39, P359